Medistim ASA (MD1) Stock Statistics & Valuation Metrics
Total Valuation
Medistim ASA has a market cap or net worth of EUR 533.45M. The enterprise value is EUR 4.48B.
- Market Cap
- EUR 533.45M
- Enterprise Value
- EUR 4.48B
Share Statistics
Medistim ASA has 18,337,336 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 18,337,336
- Owned by Insiders
- ―
- Owned by Institutions
- 3.57%
Financial Efficiency
Medistim ASA’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 20.85%.
- Return on Equity (ROE)
- 0.24
- Return on Assets (ROA)
- 0.18
- Return on Invested Capital (ROIC)
- 20.85%
- Return on Capital Employed (ROCE)
- 0.28
- Revenue Per Employee
- 3.54M
- Profits Per Employee
- 653.03K
- Employee Count
- 159
- Asset Turnover
- 0.98
- Inventory Turnover
- 0.71
Valuation Ratios
The current PE Ratio of Medistim ASA is 29.81. Medistim ASA’s PEG ratio is 1.63.
- PE Ratio
- 29.81
- PS Ratio
- 6.00
- PB Ratio
- 7.85
- Price to FCF
- 26.49
- Price to Operating Cash Flow
- 26.49
- PEG Ratio
- 1.63
Income Statement
In the last 12 months, Medistim ASA had revenue of 562.60M and earned 103.83M in profits. Earnings per share was 5.67.
- Revenue
- 562.60M
- Gross Profit
- 448.92M
- Operating Income
- 131.08M
- Pretax Income
- 134.25M
- Net Income
- 103.83M
- EBITDA
- 155.59M
- Earnings Per Share (EPS)
- 5.67
Cash Flow
In the last 12 months, operating cash flow was 138.26M and capital expenditures 0, giving a free cash flow of 138.26M billion.
- Operating Cash Flow
- 138.26M
- Free Cash Flow
- 138.26M
- Free Cash Flow per Share
- 7.55
Dividends & Yields
Medistim ASA pays an annual dividend of ―, resulting in a dividend yield of 3.35%
- Dividend Per Share
- ―
- Dividend Yield
- 3.35%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.77%
- Earnings Yield
- 3.35%
Stock Price Statistics
- Beta
- 0.54
- 52-Week Price Change
- 31.70%
- 50-Day Moving Average
- 24.34
- 200-Day Moving Average
- 20.70
- Relative Strength Index (RSI)
- 81.94
- Average Volume (3m)
- 383
Important Dates
Medistim ASA upcoming earnings date is Feb 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 23, 2026
- Next Earnings Date
- Feb 26, 2027
- Ex-Dividend Date
- ―
Financial Position
Medistim ASA as a current ratio of 4.00, with Debt / Equity ratio of 5.74%
- Current Ratio
- 4.00
- Quick Ratio
- 2.50
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.94
- Interest Coverage Ratio
- 267.50
Taxes
In the past 12 months, Medistim ASA has paid 30.41M in taxes.
- Income Tax
- 30.41M
- Effective Tax Rate
- 0.23
Enterprise Valuation
Medistim ASA EV to EBITDA ratio is 18.76, with an EV/FCF ratio of 25.35.
- EV to Sales
- 5.74
- EV to EBITDA
- 18.76
- EV to Free Cash Flow
- 25.35
- EV to Operating Cash Flow
- 25.35
Balance Sheet
Medistim ASA has EUR 183.45M in cash and marketable securities with EUR 26.17M in debt, giving a net cash position of EUR 157.28M billion.
- Cash & Marketable Securities
- EUR 183.45M
- Total Debt
- EUR 26.17M
- Net Cash
- EUR 157.28M
- Net Cash Per Share
- EUR 8.58
- Tangible Book Value Per Share
- EUR 21.36
Margins
Gross margin is 64.42%, with operating margin of 25.92%, and net profit margin of 20.13%.
- Gross Margin
- 64.42%
- Operating Margin
- 25.92%
- Pretax Margin
- 26.26%
- Net Profit Margin
- 20.13%
- EBITDA Margin
- 30.62%
- EBIT Margin
- 26.73%
Analyst Forecast
The average price target for Medistim ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 24.17%
- EPS Growth Forecast
- 30.80%
